Document Detail

Combined Ventricular Assist Device Placement With Adjustable Gastric Band (VAD-BAND): A Promising New Technique for Morbidly Obese Patients Awaiting Potential Cardiac Transplantation.
MedLine Citation:
PMID:  22505986     Owner:  NLM     Status:  PubMed-not-MEDLINE    
BACKGROUND: Morbid obesity remains a potential relative contraindication for cardiac transplantation. Hence, a select population of morbidly obese patients with end-stage heart failure may require a ventricular assist device (VAD) as a bridge to transplantation to afford them time to lose sufficient weight and thus decrease there mortality rate after transplantation. Unfortunately, obtaining suitable weight loss via dietary or exercise regimens is limited by the cardiac limitations of the patients. We report on a new procedure of combining ventricular assist device placement with adjustable gastric band (VAD-BAND) placement to facilitate sufficient weight loss for cardiac transplantation.
METHODS: We report on our experience of 2 morbidly obese (BMI 46.6, BMI 43.7) patients with severe non-ischemic cardiomyopathy who underwent a VAD-BAND placement for treatment of morbid obesity and potential future cardiac transplantation.
RESULTS: Patient 1 was a 24-year-old male with a body mass index (BMI) of 46.6 admitted in cardiogenic shock with severe non-ischemic cardiomyopathy (New York Functional Class IV, Left Ventricular Ejection Fraction 15.3%) who underwent the VAD-BAND procedure. At 11 months outpatient follow-up the patient had clinically improved with a BMI of 34.2. Patient 2 was a 36-year-old male with a body mass index of 43.7 admitted in cardiogenic shock with severe non-ischemic cardiomyopathy (New York Functional Class IV, Left Ventricular Ejection Fraction 17.1%) who underwent placement of a VAD-BAND. At 4 months post-operation, the patient was stalwart clinically with a BMI of 34.8. Both patients are now under consideration for cardiac transplantation.
CONCLUSION: In conclusion, concurrent placement of a VAD-BAND is a safe and viable option for morbidly obese patients with end-stage heart disease. Further research is needed to define indications and future clinical practice.
KEYWORDS: Gastric band; Ventricular assist device; Morbid obesity; Heart failure; Transplantation; Weight loss.
Richdeep S Gill; Shahzeer Karmali; Jeevan Nagandran; Howard O Frazier; Vadim Sherman
Related Documents :
11440496 - Cardiac surgery in octogenarians; peri-operative outcome and long-term results.
20381086 - Noninvasive estimate of left ventricular filling pressure correlated with early and mid...
10816286 - Fatal left main coronary artery embolism from aortic valve endocarditis following cardi...
968796 - Surgical treatment of congenital valvular aortic stenosis.
15639206 - Prevalence of diastolic dysfunction as a possible cause of dyspnea in the elderly.
2149566 - In vivo phosphorus-31 nmr spectroscopy of abnormal myocardial high-energy phosphate met...
Publication Detail:
Type:  Journal Article     Date:  2012-03-23
Journal Detail:
Title:  Journal of clinical medicine research     Volume:  4     ISSN:  1918-3011     ISO Abbreviation:  J Clin Med Res     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-04-16     Completed Date:  2012-08-23     Revised Date:  2012-09-10    
Medline Journal Info:
Nlm Unique ID:  101538301     Medline TA:  J Clin Med Res     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  127-9     Citation Subset:  -    
Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Risk factors associated with epidural use.
Next Document:  Carotid Intima-Media Thickness in Asymptomatic Subjects With Low Lipoprotein(a) Levels.